Search Results - "proteomics"
Suggested Topics within your search.
Suggested Topics within your search.
- Diseases
- Methodology 12
- Proteomics 12
- methods 12
- Biochemical markers 9
- Biomarkers 9
- Proteome 9
- analysis 9
- Cardiovascular Diseases 6
- Cardiovascular system 6
- Kidney Diseases 6
- Kidneys 6
- Age Factors 3
- Age factors 3
- Aging 3
- Animal models 3
- Choroid 3
- Complement Factor H 3
- Complement Membrane Attack Complex 3
- Degeneration 3
- Fetal Diseases 3
- Fetus 3
- Genetic aspects 3
- Infant, Newborn, Diseases 3
- Macular Degeneration 3
- Models, Animal 3
- Models, Genetic 3
- Models, Molecular 3
- Nervous System Diseases 3
- Nervous system 3
-
1
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
2
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
3
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
4
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
5
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
6
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
7
Application of proteomics in fetal and neonatal medicine
Published 2013Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
Get full text
Series
Electronic Video -
8
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
9
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
10
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
11
Application of proteomics in fetal and neonatal medicine
Published 2013Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
Get full text
Series
Electronic Video -
12
Application of proteomics in fetal and neonatal medicine
Published 2013Table of Contents: “…Contents: Application of proteomics in fetal and neonatal medicine -- Principles -- Samples -- Techniques -- Statistics -- Application to obstructive nephropathy in newborns -- Application in neonatal medicine -- Conclusion.…”
Get full text
Series
Electronic Video -
13
The choroid in aging and disease
Published 2016Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
Get full text
Series
Electronic Video -
14
The choroid in aging and disease
Published 2016Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
Get full text
Series
Electronic Video -
15
The choroid in aging and disease
Published 2016Table of Contents: “…Contents: Age-related Macular Degeneration (AMD) -- Drusen -- Atrophy -- Vascular changes -- Proteomics of choroidal thinning -- Fibrosis -- CD34 -- C-reactive protein accumulation -- Complement cascade: Membrane Attack Complex (MAC).…”
Get full text
Series
Electronic Video -
16
-
17
Deciphering neurodegeneration models and methods /
Published 2014Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
Get full text
Series
Electronic Video -
18
Deciphering neurodegeneration models and methods /
Published 2014Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
Get full text
Series
Electronic Video -
19
Deciphering neurodegeneration models and methods /
Published 2014Table of Contents: “…Contents: Deciphering Neurodegeneration: Models and Methods -- The challenge of neurodegeneration -- Huge diversity in cell types -- Nature versus nurture -- Reductionism versus systems biology -- Cellular models -- Yeast -- Primary cells -- Cell lines -- Stem cells -- Model organisms -- Caenorhabditis elegans -- Drosophila melanogaster -- Zebrafish -- Danio rerio -- Rodents -- Molecular biology approaches -- Knock out and knock in -- Genomic editing -- RNAi -- Overexpression -- Gene expression -- rtPCR -- Microarrays -- RNAseq -- Protein analysis -- Immunoblot -- ELISA -- Mass spec and proteomics -- Microscopy -- Immunocytochemistry -- Live cell imaging -- Electrophysiology.…”
Get full text
Series
Electronic Video